Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 42

1.

The dose-response model for dioxin.

Byrd DM 3rd, Allen DO, Beamer RL, Besch HR Jr, Bylund DB, Doull J, Fleming WW, Fries A, Guengerich FP, Hornbrook R, Lasagna L, Lum BK, Michaelis EK, Morgan ET, Poland A, Rozman KK, Smith JB, Swanson HI, Waddell W, Wilson JD.

Risk Anal. 1998 Feb;18(1):1-2. No abstract available.

PMID:
9556441
2.

Effects of nicardipine in rats subjected to endotoxic shock.

Lee HC, Hardman JM, Lum BK.

Gen Pharmacol. 1992 Jan;23(1):71-4.

PMID:
1592229
4.

Protective action of calcium entry blockers in endotoxin shock.

Lee HC, Lum BK.

Circ Shock. 1986;18(3):193-203. Erratum in: Circ Shock 1986;20(1):81.

PMID:
2938842
5.

Role of cyclic AMP in adrenergically-induced tracheal muscle relaxation.

Lau YS, Lum BK.

Arch Int Pharmacodyn Ther. 1983 Jan;261(1):36-50.

PMID:
6133508
6.

Protective action of diazepam and of sympathomimetic amines against amitryptyline-induced toxicity.

Follmer CH, Lum BK.

J Pharmacol Exp Ther. 1982 Aug;222(2):424-9.

PMID:
7097563
7.

Experimental studies on the effects of physostigmine and of isoproterenol on toxicity produced by tricyclic antidepressant agents.

Lum BK, Follmer CH, Lockwood RH, Thomas HM.

J Toxicol Clin Toxicol. 1982 Mar;19(1):51-65.

PMID:
7154141
8.

Imaging through atmospheric turbulence with annular pupils.

Mahajan VN, Lum BK.

Appl Opt. 1981 Sep 15;20(18):3233-7. doi: 10.1364/AO.20.003233.

PMID:
20333126
9.

Effects of cardiac stimulants of amitriptyline toxicity.

Follmer CH, Lockwood RH, Lum BK.

Proc West Pharmacol Soc. 1981;24:79-82. No abstract available.

PMID:
7255491
10.

Study of a cardiotonic fraction from an extract of the seaweed. Undaria pinnatifida.

Searl PB, Norton TR, Lum BK.

Proc West Pharmacol Soc. 1981;24:63-5. No abstract available.

PMID:
6265957
11.

Studies on the hyperglycemia and hepatic glycogenolysis produced by alpha and beta adrenergic agonists in the cat.

Lum BK, Lau YS, Buesa R, Lockwood RH, Kuo SH.

Life Sci. 1980 Apr 14;26(15):1195-202. No abstract available.

PMID:
6104762
12.

The hyperglycemic response to alpha and beta adrenergic agonists in the cat.

Lum BK, Lau YS, Lockwood RH, Kuo SH.

Proc West Pharmacol Soc. 1979;22:183-8. No abstract available.

PMID:
42084
13.

Effects of adrenalectomy and adrenergic antagonists on potassium metabolism.

Lockwood RH, Lum BK.

J Pharmacol Exp Ther. 1977 Oct;203(1):103-11.

PMID:
909045
14.

Adrenergic receptor mechanisms involved in the hyperglycemia and hyperlactic-acidemia produced by sympathomimetic amines in the cat.

Kuo SH, Kamaka JK, Lum BK.

J Pharmacol Exp Ther. 1977 Aug;202(2):301-9. No abstract available.

PMID:
18597
15.

Cardiotoxic interactions between sympathomimetic amines and ouabain.

Lum BK, Yano SS, Yatsushiro GN.

Proc West Pharmacol Soc. 1977;20:275-80. No abstract available.

PMID:
896835
16.

Role of cyclic AMP in adrenergically induced tracheal smooth muscle relaxation.

Lau YS, Lum BK.

Proc West Pharmacol Soc. 1977;20:33-9. No abstract available.

PMID:
197544
17.

Studies on the effects of sympathomimetic amines on carbohydrate metabolism.

Kuo SH, Khan SB, Kamaka JK, Martin BK, Lum BK.

Proc West Pharmacol Soc. 1975;18:232-5. No abstract available.

PMID:
1178675
18.

Effects of adrenergic agonists and antagonists on potassium metabolism.

Lockwood RH, Lum BK.

J Pharmacol Exp Ther. 1974 Apr;189(1):119-29. No abstract available.

PMID:
4823287
19.

Studies on the intestinal actions of tyramine.

Heilman RD, Lum BK.

Med Biol. 1974 Feb;52(1):39-47. No abstract available.

PMID:
4220377
20.

Selective adrenergic stimulant actions of 1-isopropylamino-3-(2-thiazoloxy)-2-propanol (ITP) in anesthetized cats.

Lockwood RH, Lum BK.

Life Sci. 1974 Jan 1;14(1):73-81. No abstract available.

PMID:
4149302
21.

Effects of nicotine and sympathomimetic amines on potassium intoxication.

Lum BK, Lockwood RH.

J Pharmacol Exp Ther. 1972 Apr;181(1):147-54. No abstract available.

PMID:
4401177
22.

Studies on the intestinal relaxation produced by dopamine.

Heilman RD, Lum BK.

J Pharmacol Exp Ther. 1971 Jul;178(1):63-72. No abstract available.

PMID:
4397264
23.

Potentiation of the pressor response to angiotensin by amphetamine and ephedrine.

Commarato MA, Lum BK.

Eur J Pharmacol. 1970 Apr;10(1):25-33. No abstract available.

PMID:
4314997
24.

Cardiovascular interactions of amphetamine and ephedrine with norepinephrine and with vasopressin.

Commarato MA, Lum BK.

Eur J Pharmacol. 1969 Aug;7(2):125-34. No abstract available.

PMID:
5345989
25.

Selective augmentation of the pressor responses to catecholamines by metanephrine.

Allen DO, Calvert DN, Lum BK.

J Pharmacol Exp Ther. 1969 Jun;167(2):309-18. No abstract available.

PMID:
4306903
26.

The effects of hemorrhagic shock upon blood pressure responses to adrenergic agents and upon tissue catecholamines.

Calvert DN, Lum BK.

J Pharmacol Exp Ther. 1968 Jan;159(1):74-81. No abstract available.

PMID:
5643952
27.

Protection against traumatic shock by pretreatment with quindonium bromide.

Lum BK, Allen DO.

Arch Int Pharmacodyn Ther. 1967 Sep;169(1):185-8. No abstract available.

PMID:
6055127
28.

Selective loss of responsiveness to alpha adrenergic receptor stimulation after cold storage of the rabbit intestine.

Lum BK, Heilman RD, Gaunt MA.

Eur J Pharmacol. 1967 Mar;1(2):109-13. No abstract available.

PMID:
4383493
29.
30.

Blockade of epinephrine- and ouabain-induced cardiac arrhythmias in the dog heart-lung preparation.

Somani P, Lum BK.

J Pharmacol Exp Ther. 1966 May;152(2):235-42. No abstract available.

PMID:
4380269
31.

Antagonism of epinephrine-induced cardiac arrhythmias by 4-(2-isopropylamino-1-hydroxyethyl)-methanesulfonanilide (MJ 1999) .

Somani P, Fleming JG, Chan GK, Lum BK.

J Pharmacol Exp Ther. 1966 Jan;151(1):32-7. No abstract available.

PMID:
5902176
32.

The beta-adrenergic blocking agents pharmacology and structure-activity relationships.

Biel JH, Lum BK.

Fortschr Arzneimittelforsch. 1966;10:46-89. Review. No abstract available.

PMID:
4860334
33.

THE ANTIARRHYTHMIC ACTIONS OF BETA ADRENERGIC BLOCKING AGENTS.

SOMANI P, LUM BK.

J Pharmacol Exp Ther. 1965 Feb;147:194-204. No abstract available.

PMID:
14259497
34.

TREATMENT OF CARDIAC ARRHYTHMIAS.

LUM BK.

Wis Med J. 1965 Feb;64:116. No abstract available.

PMID:
14255878
35.

DRUG TREATMENT OF MIGRAINE HEADACHE.

LUM BK.

Wis Med J. 1964 Feb;63:132-3. No abstract available.

PMID:
14121833
36.

PHARMACOLOGY OF METHYLDOPA; AN ANTIHYPERTENSIVE DRUG.

LUM BK.

Wis Med J. 1963 Aug;62:353-5. No abstract available.

PMID:
14048612
37.

Protection against traumatic shock by guanethidine, bretylium and betaTM 10.

LUM BK, CALVERT DN.

J Pharmacol Exp Ther. 1962 Oct;138:74-7. No abstract available.

PMID:
13931638
38.

Newer agents which inhibit sympathetic nerve activity.

LUM BK.

Wis Med J. 1962 Sep;61:429-30. No abstract available.

PMID:
14467322
39.

Potentiation of vasoactive drugs by ganglionic blocking agents.

LUM BK, RASHLEIGH PL.

J Pharmacol Exp Ther. 1961 Apr;132:13-8. No abstract available.

PMID:
13764245
40.

A method for analyzing the effect of pH and the ionization of drugs upon cardiac tissue with special reference to pentobarbital.

HARDMAN HF, MOORE JI, LUM BK.

J Pharmacol Exp Ther. 1959 Jun;126(2):136-42. No abstract available.

PMID:
13665519
41.

Analysis of the common carotid occlusion pressor reflex in the anesthetized dog.

HARDMAN HF, BAIRD WM, SUITS DB, LUM BK.

Am J Physiol. 1959 Feb;196(2):445-8. No abstract available.

PMID:
13627198
42.

Cardiac arrhythmias induced by tolazoline (priscoline).

LUM BK, NICKERSON M.

J Pharmacol Exp Ther. 1956 Feb;116(2):156-63. English, Russian. No abstract available.

PMID:
13296030

Supplemental Content

Support Center